[PSTX] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[PSTX] Poseida Therapeutics, Inc.
Announcement Date
09-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -20.67%
YoY- 32.03%
Quarter Report
PSTX's Result
PSTX's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 24,995 9,352 20,013 10,343 9,921 116,306 2,700 339.10%
PBT -25,349 -31,671 -27,456 -38,847 -33,026 70,661 -43,036 -29.66%
Tax -6,040 -107 4,681 1,359 292 252 1,491 -
NP -23,990 -31,778 -27,456 -40,206 -33,318 70,409 -44,527 -33.71%
Tax Rate - - - - - -0.36% - -
Total Cost 48,985 41,130 47,469 50,549 43,239 45,897 47,227 2.45%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -95.98 -339.80 -137.19 -388.73 -335.85 60.54 -1,649.15 -84.90%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.27 -0.35 -0.32 -0.47 -0.39 0.92 -0.71 -47.41%
EPS Diluted -0.27 -0.35 -0.32 -0.47 -0.39 0.92 -0.71 -47.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.